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The present study shows that systemic dopamine r ceptor blockade impaired movement initiation of rats, trained in a simple 
reaction time task for rapid initiation of locomotion i response to a combined optic/acoustic cue. Reaction time, movement time 
and the accelerative force were recorded for each initiation of locomotion. Results indicate a dose-related increase of reaction 
time following systemic administration f haloperidol (0.1, 0.15, 0.3 mg/kg i.p.). Measures derived from resulting force-time 
patterns howed a haloperidol-induced d crease (0.15 mg/kg i.p.) of the mean rate of force development, indicating a decreased 
initial acceleration. These effects were reversed by systemic o-administration of dizocilpine (MK-801) (0.08 mg/kg i.p.), a 
selective non-competitive N-methyl-D-aspartate (NMDA) antagonist. The haloperidol-induced movement initiation deficits in 
this task are in part comparable to akinesia seen in Parkinson's disease and their reversal by dizocilpine has implications for 
the treatment of this disease. 
Blockade of central dopaminergic (DA) trans- 
mission by DA receptor antagonists in rats pro- 
duces selective motor impairments. One hypothe- 
sis proposed to account for neuroleptic-induced 
disturbances of behavior is that these drugs pre- 
dominantly affect animals' ability to initiate motor 
behavior 13. This hypothesis is based on findings 
of neuroleptic-treated animals showing akinesia, 
catalepsy, prolonged reaction time and further 
impairments of motor control in a variety of other 
behavioral paradigms (for refs. see 1, 13), and 
these symptoms are, at least in part, due to a 
movement initiation deficit. The work reported 
here investigated the effect of haloperidol on ini- 
tiation of locomotion of rats using a newly 
designed reaction time task. Neuroleptics are 
known to delay locomotor initiation in rats in an 
active avoidance paradigm and this impairment 
appeared not to be related to a disruption of sen- 
sory or motivational processes 9. In our study, we 
examined initiation of locomotion using a 
rewarded reaction time task: food-deprived rats 
were trained in a modified runway for rapid loco- 
motor initiation in response to a cue to get a food 
reward. Movement initiation was recorded by 
high performance video equipment and a force 
platform to detect ground reaction forces exerted 
by an animal on the surface. This device is espe- 
Correspondence: W. Hauber, Department of Neuropharmacology, University of Tfibingen, Mohlstr. 54/1, D-7400 Tfibingen, 
F.R.G. 
0166-4328/90/$03,50 © 1990 Elsevier Science Publishers B.V. (Biomedical Division) 
162 
cially appropriate for evaluating time and force 
parameters of locomotor initiation and is there- 
fore sensitive to akinesic effects in terms of 
reaction time, movement time as well as changes 
of force-time patterns. Since subtle changes of 
force production seem to be associated with DA 
dysfunction in rats and humans 5'6"16, analysis of 
force parameters may be a useful tool regarding 
neuroleptic effects on movement initiation. We 
further investigated in the paradigm used here, 
dizocilpine, a selective antagonist of the gluta- 
matergic transmission mediated by N-methyl- 
D-aspartate (NMDA) receptors, which was 
recently found to have a marked anticataleptic 
activity ~ and pronounced stimulatory effects on 
locomotion 3.As haloperidol was expected to act 
akinesic in the paradigm used here, dizocilpine 
should antagonize these deficits. 
Eight male Sprague-Dawley rats, weighing 
240-260g were purchased from Interfauna 
(Tuttlingen, F.R.G.). The animals were housed in 
groups (4 per cage) and provided with 12 g rodent 
laboratory chow per rat each day and water 
ad libitum. The temperature in the colony room 
was kept constant at 22 + 3 °C and lights were on 
between 6.00 and 18.00 h. Animals were trained 
on a newly designed reaction time paradigm 7.
Briefly, behavioral testing was conducted in a 
modified runway made of transparent perspex: it 
consisted of a start box (22 x 9 x 9cm) and a 
runway (100 x 9 x 9 cm) terminating in a goal 
box (22 x 9 x 9 cm). The food-deprived rat was 
placed in the start box with the face to a guillotine 
door blocking the entrance to the runway. After 
a variable delay (3-10 s), a combined light/tone 
cue signalled the simultaneous opening of the 
front door. In response to the cue, a rat initiated 
from a starting position (upright posture, paws on 
the ground) rapid locomotion and moved 
straightforward through the runway to the goal 
box to receive a reward in a baited food cup 
(45 mg pellet, Noyes). Approximately 30 s later, 
the rat was replaced from the goal box into the 
start box for a new trial. The transition from 
stance to gait was recorded by means of high 
performance video equipment (Panasonic 
WV130 CCD camera, AG6200 recorder and 
WJ810 time generator) and evaluated by frame- 
by-frame analysis. In addition, dynamic indices of 
movement initiation were recorded with a sensi- 
tive biaxial force platform mounted below the 
start box: integrated force transducers (strain 
gauges) connected with an operation amplifier 
and PC-compatible oscilloscope (ITT-metrix 
OX750/2) provided an exact measurement of ver- 
tical and horizontal (anterior-posterior) ground 
reaction forces exerted by an animal on the sur- 
face. Force-time waveforms of each response 
emitted by the subjects showed a reproducible 
pattern and were used to analyse dynamic fea- 
tures of movement initiation. It has been shown 
that peak force and rate of force development 
(slope) of the anterior-posterior component of 
ground reaction forces are sensitive and reliable 
parameters for characterizing the initial accelera- 
tion in the forward direction. The following 
measures were recorded from each trial: correct 
reaction time (RT), defined as latency between 
cue presentation and movement initiation (first 
complete lifting of a paw from the surface) within 
a range of 100-1000 ms, correct movement time 
defined as latency from movement initiation up to 
leaving the force platform within a range of 
100-1500 ms, peak force and rate of force devel- 
opment (force slope) of anterior-posterior 
ground reaction forces. Rats readily learned this 
task and a stable performance of all rats was 
established in 10 training sessions. One daily 
session consisted of 10 successive trials per 
animal. The following experimental design and 
analysis was used: after the training sessions, the 
experiment was performed on consecutive days 
with one daily session. The following drugs were 
used for intraperitoneal administration: saline 
solution (0.9~ o sodium chloride, l ml/kg i.p.); 
dizocilpine (MK-801) ([( + )-5-methyl-10,11-di- 
hydroxy-5 H-dibenz(a,d)cyclohepten- 5,10-imine ] 
hydrogen maleate) (Biotrend, KOln, F.R.G.) and 
haloperidol (Sigma, Deissenhofen, F.R.G.), dis- 
solved in saline solution, respectively. Injections 
were given 30 min prior to the onset of individual 
behavioral testing (injection volume 1 ml/kg i.p.) 
according to the time-effect profile of both 
drugs~ 1. The baseline performance of all animals 
(n = 8) was tested in 3 saline sessions (one initial 
and 2 intermediate sessions) and compared to the 
performance in drugged sessions of the same ani- 
mals. In the drug sessions one drug/drug combi- 
nation was given at the following doses, respec- 
tively: haloperidol 0.1;0.15; 0.3 mg/kg i.p.; dizo- 
cilpine 0.08 mg/kg. Reaction time was recorded of 
all sessions. As RT performances in saline 
sessions were not significantly different as 
revealed by ANOVA, saline RT data were pooled 
and compared to the performance in the drug 
sessions. Movement time and force data were 
recorded from a single dose/dose combination of 
the drugs (dizocilpine 0.08 mg/kg, haloperidol 
0.15 mg/kg and co-administration at this dose) 
and compared with the data of the corresponding 
saline session. The results are presented as means 
of correct rials per session (+_ S.E.M.). The data 
of saline and drug sessions were submitted to an 
analysis of variance (ANOVA), and, in case of 
significant differences of the means, followed by 
a Newmann-Keuls  (NK) test for unequal n's and 
a posteriori pairwise comparison of differences. 
Statistical significance was admitted if the P-value 
was less than 0.05. 
RT measurements indicated that performance 
of saline sessions remained stable and an analysis 
of variance confirmed that differences of means 
between saline sessions (222.2 + 10.4 ms, 
n = 80; 233.3 + 7.4 ms, n = 77; 229.5 _+ 9.6 ms, 
n = 72) were stastistically insignificant 
(F2.226 = 0.087, df = 3.0, P > 0.05). As compared 
to performance in saline sessions, haloperidol 
induced a dose-related increase of RT. Analysis 
of variance revealed significant differences of drug 
and saline sessions (F6,638 = 12.7, d f= 2.85, 
P < 0.01 ;) and the NK test showed that halo- 
peridol induced significant RT deficits 
(0.1mg/kg, P<0.05;  0.15mg/kg, P<0.01;  
0.3 mg/kg, P < 0.01). Dizocilpine (0.08 mg/kg), 
given alone, caused a modest decrease of RT 
(P > 0.05, NK-test) and completely antagonized 
the lower dose of haloperidol (0.15mg/kg) 
(P < 0.01, NK-test). The RT deficit induced by 
the higher dose of haloperidol (0.3 mg/kg) was 
reduced significantly to about the same degree 
following dizocilpine coadministration (P < 0.01, 
NK-test). However, this antagonism was only 
partial, since RT remained significantly different 
from saline level (P < 0.05, NK-test) (see Fig. 1). 
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Fig. 1. Change of mean correct reaction time (+_ S.E.M.) 
induced by systemic administration (i.p.) of haloperidol 
and/or dizocilpine t sted in one session (10 trials per animal), 
respectively. The drug-induced changes refer to baseline per- 
formance of the same animals (n = 8) tested in one initial and 
two intermediate saline (1 ml/kg i.p.) sessions (mean reaction 
time of pooled saline sessions: 228.3 + 9.5 ms, n = 229). 
Asterisks indicate significant differences between drug and 
saline sessions (*P< 0.05, **P< 0.01), circles indicate sig- 
nificant differences between drug sessions (°P<0.05, 
° °P < 0.01) (ANOVA followed by Newmann-Keuls test). D 
0.08: dizocilpine 0.08mg/kg, n = 80; H 0.1: haloperidol 
0.1 mg/kg, n= 78; H 0.15: haloperidol 0.15 mg/kg, n= 58; H 
0.3: haloperidol 0.3 mg/kg, n = 62; D 0.8 + H 0.15: dizo- 
cilpine 0.08 mg/kg and haloperidol 0,15 mg/kg, n = 75; D 
0.08+ H 0.3: dizocilpine 0.08mg/kg and haloperidol 
0.3 mg/kg, n = 63). 
There was also a considerable reduction of the 
number of correct trials within the measured 
range from 100 to 1000 ms, as latencies often 
reached 1-5 s or animals failed to respond (see 
Fig. 1). 
Movement time measures showed a mild 
decrease of mean movement time following dizo- 
cilpine administration (0.08mg/kg) and an 
increase following haloperidol administration 
(0.15 mg/kg) as compared to the saline session 
(mean movement time: 610.8 _+ 40.2 ms, n = 64). 
However, these effects were less marked and 
statistically insignificant (,63,217 = 9.3, d f= 3.9 
P< 0.01; haloperidol, P> 0.05; dizocilpine, 
P> 0.05; haloperidol + dizocilpine P> 0.05, 
NK-test) (see Fig. 2). 
Haloperidol further impaired a dynamic apac- 
ity of the animals. As indicated in Fig. 3, halo- 
peridol and/or dizocilpine in the dose tested, only 
mildly affected mean peak force during movement 
initiation as compared with saline treatment 
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Fig. 2. Change of mean correct movement time (_+ S.E.M.) 
induced by systemic administration of haloperidol 
(0.15 mg/kg i.p., n = 39), dizocilpine (0.08 mg/kg i.p., n = 68) 
and co-administration f both drugs at this dose (n = 50) 
tested in one session (10 trials per animal), respectively. The 
drug-induced changes refer to baseline performance of the 
same animals (n = 8) tested in a saline (1 ml/kg i.p., n = 64) 
session (mean movement time: 610.8 + 40.2 ms). The dif- 
ferences between drug and saline sessions are insignificant 
(ANOVA followed by Newmann-Keuls test). D 0.08: dizo- 
cilpine 0.08mg/kg; H 0.15: haloperidol 0.15mg/kg; D 
0.08+ H 0.15: dizocilpine 0.08mg/kg and haloperidol 
0.15 mg/kg. 
(mean peak force: 0.56 + 0.04 N, n = 66), 
(F3,230 = 6.06, d f= 3.9, P<0.01 ;  dizocilpine, 
P > 0.05; haloperidol, P > 0.05 ; haloperidol + 
dizocilpine, P > 0.05, NK-test) .  In contrast, halo- 
peridol induced a significant decrease of  force 
slopes from saline level (mean force slope" 
8.9 + 0.7 N/s, n = 66) (F3,23 o = 4.98, df  = 3.9, 
P < 0.01; haloperidol, P < 0.01, dizocilpine, 
P > 0.05, NK-test) .  Therefore the ability of  rapid 
development of  force to accelerate in the forward 
direction was impaired in a way that the time 
required to generate force is lengthened, as peak 
force was not altered. Dizoci lpine reversed this 
effect in haloperidol-treated animals (P< 0.01, 
NK-test).  
The simple react ion- t ime task presented here 
used rapid locomotor  initiation as a paradigm to 
investigate movement  initiation in rats. The task 
was rapidly learned by the animals and the 
rewarded nature of  the task in combinat ion with 
a gradual food-deprivat ion was sufficient o pro- 
duce consistent responses. The device permitted 
the measurement  of parameters known to be sen- 
sitive to DA dysfunct ion (see Introduct ion) and 
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Fig. 3. Change of mean peak force (+ S.E.M.) (top) and 
force slope (_+ S.E.M.) (bottom) of the accelerative force 
induced by systemic administration of haloperidol 
(0.15 mg/kg i.p., n = 29), dizocilpine (0.08 mg/kg i.p., n = 79) 
and co-administration f both drugs at this dose (n = 60) 
tested in one session (10 trials per animal), respectively. The 
drug-induced changes refer to baseline performance of the 
same animals (n = 8) tested in a saline (1 ml/kg i.p., n = 66) 
session (mean peak force: 0.56 + 0.04 N; mean force slope: 
8.9 + 0.7N/s). Asterisks indicate significant differences 
between drug and saline session (**P < 0.01 ), circles indicate 
significant differences between drug sessions (° °P < 0.01) 
(ANOVA followed by Newmann-Keuls test. D 0.08: dizocil- 
pine 0.08 mg/kg; H 0.15: hatoperidol 0.15 mg/kg; D 0.08 + H 
0.15: dizocilpine 0.08 mg/kg and dizocilpine 0.08 mg/kg). 
the results show that systemic DA receptor 
b lockade by haloperidol impaired different 
aspects of  locomotor  initiation. Systemic 
coadministrat ion of  dizocilpine, a selective 
NMDA antagonist, improved these movement  
initiation deficits. 
The RT of the animals measured in the saline 
condition (range 100-300 ms) of this task corre- 
spond well to the response latencies obtained in 
other paradigms 1"8"13-L5. Haloperidol treatment 
induced a dose-related increase of RT, accompa- 
nied by a decrease of correct trials (movement 
initiation within 1 s). These findings are con- 
sistent with earlier observations of neuroleptic 
actions on RT supporting the concept of a DA 
involvement in the initiation of movement ~'~3"~4. 
Previous work using an active avoidance task has 
shown a similar deficit in the initiation of loco- 
motion. In this study, chlorpromazine suppressed 
avoidance behavior which is due to a delayed 
locomotor initiation and not to a disruption of 
sensory or motivational processes 9. Thus, the RT 
deficit seen here most probably reflects impaired 
movement initiation. However, a decrease of cor- 
rect trials may indicate an attenuation of the 
rewarding properties of food reward. Although 
interference by reward attenuation cannot be 
ruled out, the animals did not neglect food reward 
in correct and even incorrect (latency over 1 s) 
trials. In addition, haloperidol was found to 
enhance feeding behavior of rats 2. 
Regarding the effects of haloperidol on move- 
ment time, results indicate that haloperidol 
caused only a slight increase of movement time. 
This finding is in line with observations in a dis- 
criminated lever release (DLR) task where halo- 
peridol was found to increase response duration 
due to a slowing in the animal's paw removal from 
the operandum 6. However, the increase of move- 
ment time was less pronounced and therefore 
insignificant in our study. 
In order to assess animals' dynamic capacities 
during initiation of locomotion, ground reaction 
forces were recorded by means of a force plat- 
form. Measures derived from resulting force-time 
patterns of the horizontal component showed a 
haloperidol-induced decrease of the mean rate of 
force development, while the mean peak force was 
not affected significantly. Thus, haloperidol 
reduced initial acceleration during locomotor ini- 
tiation. However, arecent study using a DLR task 
shows that in rats haloperidol increased emitted 
peak force while pressing a force-sensitive 
manipulandum and prolonged the mean time for 
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force to drop from its peak value during response 
termination 6. These deficits are attributable to 
haloperidol's tendency to exaggerate static 
postural support mechanisms, e.g. to remain in 
the same postural position 4"6. It is likely that the 
same underlying mechanism accounts for the dif- 
ferent force deficit observed in the present para- 
digm, since an increase of postural support 
mechanisms could prevent an appropriate force 
development during transition from stance to gait. 
Lower rates of force development are also found 
in humans with PD tested in a force production 
task, suggesting a relation between DA dys- 
function and deficient regulation of force and time 
parameters 16. 
Dizocilpine, given alone, showed marked sti- 
mulatory effects on motor behavior, as indicated 
by mild but insignificant decreases of RT and 
movement time as well as slight increases in peak 
force and force slope. Furthermore, systemic o- 
administration of dizocilpine reversed halo- 
peridol-induced movement initiation deficits. 
These findings are congruent with studies show- 
ing that dizocilpine antagonised haloperidol- 
induced catalepsy 11and exerted locomotor stimu- 
latory effects in monoamine-depleted mice 3. 
Regarding underlying mechanisms mediating 
behavioral effects of NMDA antagonists, it has 
been proposed that DA and glutamate (via the 
NMDA receptor) exert opposite actions on 
striatally mediated behavior 1°. Thus, striatal 
NMDA receptor blockade antagonizes behav- 
ioral impairments due to DA deficits in rats, and 
these findings have implications for the treatment 
of PD 12. Similar mechanisms may account for the 
antagonism observed here, since movement ini- 
tiation is highly dependent on intact striatal DA 
transmission 8"14"~5. However, this conclusion is 
limited due to the systemic administration of 
drugs in the present study. Haloperidol-induced 
motor symptoms resemble in part those of PD in 
humans, and, therefore, neuroleptic-induced 
akinesia in animals is sometimes used as a model 
for this disease. The movement initiation deficits 
observed here following haloperidol treatment are 
reminiscent of symptoms in patients with PD and 
their reversal by dizocilpine further corroborates 
recent findings suggesting a therapeutic potential 
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of NMDA antagonists in the treatment of this 
disease. 
The present results should be considered as 
preliminary awaiting more extensive studies with 
full dose-response characteristics. We wish to 
thank Dr. P. Lindenm~iller, University of 
Stuttgart (Institute of Design and Production in 
Precision Engineering) for developing the force 
measuring unit. This research was supported by 
Deutsche Forschungsgemeinschaft (SFB 307). 
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